Patient Education Series | Transcatheter Aortic Valve Replacement | Thomas M. Chengot, DO, FACC, FSCAI, FASE, FASNC, RPVI
Dr. Thomas Chengot is a highly skilled interventional and structural cardiologist practicing at the Amityville Heart Center in New York. He is experienced in diagnosing, monitoring, and treating a range of cardiovascular conditions, including heart attacks, coronary heart disease, and hypertension. Dr. Chengot specializes... more
Transcatheter Aortic Valve Replacement (TAVR) stands out as a groundbreaking procedure that has transformed how aortic valve disease is treated. Traditionally, addressing this condition necessitated open-heart surgery, bringing substantial risks and extended recovery periods. Enter TAVR, a minimally invasive alternative that has truly revolutionized cardiac care.
This innovative approach involves replacing a diseased aortic valve using a catheter-based method, negating the need for a large incision and sternotomy. It is particularly advantageous for patients at high risk or considered inoperable for conventional valve replacement surgery. Predominantly, TAVR addresses aortic valve stenosis, where the valve becomes rigid and constricted.
The advantages of TAVR are considerable. Compared to the traditional surgery, TAVR boasts shorter hospital stays, quicker recovery, and fewer complications. Immediate relief from symptoms like shortness of breath, chest pain, and fatigue is common, significantly enhancing the quality of life. Furthermore, the minimally invasive nature results in reduced scarring and a lower infection risk.
Despite its merits, TAVR does come with potential risks, including bleeding, infection, stroke, and valve-related issues like leakage or blockage. These risks are contingent on individual health, age, and other factors. Therefore, consulting healthcare providers is crucial for patients to determine TAVR's suitability and understand the specific benefits and risks for their case.
https://www.findatopdoc.com/doctor/130468-Thomas-Chengot-Cardiologist
